Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
ROE: Returns Declining
Trending lower, below historical average, strong compound growth.
Left:
||||
Return on equity
Latest
-89.60%
↓ 129% below average
Average (5y)
-39.08%
Historical baseline
Range
High:-21.98%
Low:-89.60%
CAGR
+23.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -89.60% | -150.1% |
| 2023 | -35.82% | -63.0% |
| 2022 | -21.98% | +18.3% |
| 2021 | -26.91% | +5.4% |
| 2020 | -28.46% | +10.2% |
| 2019 | -31.71% | - |